PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Götz, A. ; Lehti, M.* ; Donelan, E.* ; Striese, C. ; Cucuruz, S. ; Sachs, S. ; Yi, C.X.* ; Woods, S.C.* ; Wright, S.D.* ; Tschöp, M.H. ; Gao, Y.* ; Hofmann, S.M.

Circulating HDL levels control hypothalamic astrogliosis via apoA-I.

J. Lipid Res. 59, 1649-1659 (2018)
Verlagsversion Postprint DOI PMC
Open Access Gold
Meta-inflammation of hypothalamic areas governing energy homeostasis has recently emerged as a process of potential pathophysiological relevance for the development of obesity and its metabolic sequelae. The current model suggests that diet-induced neuronal injury triggers microgliosis and astrocytosis, conditions which ultimately may induce functional impairment of hypothalamic circuits governing feeding behavior, systemic metabolism, and body weight. Epidemiological data indicate that low circulating HDL levels, besides conveying cardiovascular risk, also correlate strongly with obesity. We simulated that condition by using a genetic loss of function mouse model (apoA-I/) with markedly reduced HDL levels to investigate whether HDL may directly modulate hypothalamic inflammation. Astrogliosis was significantly enhanced in the hypothalami of apoA-I/ compared with apoA-I+/+mice and was associated with compromised mitochondrial function. apoA-I/ mice exhibited key components of metabolic disease, like increased fat mass, fasting glucose levels, hepatic triglyceride content, and hepatic glucose output compared with apoA-I+/+controls. Administration of reconstituted HDL (CSL-111) normalized hypothalamic inflammation and mitochondrial function markers in apoA-I/ mice. Treatment of primary astrocytes with apoA-I resulted in enhanced mitochondrial activity, implying that circulating HDL levels are likely important for astrocyte function. HDL-based therapies may consequently avert reactive gliosis in hypothalamic astrocytes by improving mitochondrial bioenergetics and thereby offering potential treatment and prevention for obesity and metabolic disease.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.505
1.300
4
4
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Mitochondria ; Inflammation ; High Density Lipoprotein ; Apolipoprotein A-i ; Metabolism ; Dyslipidemia ; Adipose Tissue ; Hypothalamus ; Astrocytes; High-density-lipoprotein; Aortic Endothelial-cells; Alzheimers-disease; Reactive Gliosis; Protein-kinase; Obesity; Inflammation; Astrocytes; Mice; Transcytosis
Sprache englisch
Veröffentlichungsjahr 2018
HGF-Berichtsjahr 2018
ISSN (print) / ISBN 0022-2275
e-ISSN 1539-7262
Zeitschrift Journal of Lipid Research
Quellenangaben Band: 59, Heft: 9, Seiten: 1649-1659 Artikelnummer: , Supplement: ,
Verlag American Society for Biochemistry and Molecular Biology
Verlagsort 9650 Rockville Pike, Bethesda, Md 20814-3996 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Obesity (IDO)
Institute of Diabetes and Regeneration Research (IDR)
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502200-001
G-502390-001
DOI 10.1194/jlr.M085456
WOS ID WOS:000442983100012
Scopus ID 85052649549
PubMed ID 29991652
Erfassungsdatum 2018-07-16
[➜Korrektur melden]